Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response

Neuropharmacology

Volumn 77, Issue , 2014, Pages 200-207

  Halberstadt, Adam L ^a   Geyer, Mark A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

5 HT2A; Head twitch; LSD; Psychedelic

Indexed keywords

2,5 DIMETHOXY 4 IODOPHENETHYLAMINE; N (2 METHOXYBENZYL) 2,5 DIMETHOXY 4 IODOPHENETHYLAMINE; N (2,3 METHYLENEDIOXYBENZYL) 2,5 DIMETHOXY 4 IODOPHENETHYLAMINE; PHENETHYLAMINE DERIVATIVE; PSYCHEDELIC AGENT; UNCLASSIFIED DRUG; VOLINANSERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; HEAD TWITCH; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

5-HT2A; HEAD TWITCH; LSD; PSYCHEDELIC;

ANIMALS; DIMETHOXYPHENYLETHYLAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HALLUCINOGENS; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; SEROTONIN 5-HT2 RECEPTOR AGONISTS;

EID: 84886246365     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.08.025     Document Type: Article

References (45)

1. 2C receptors Br. J. Pharmacol. 136 2002 510 519 (Pubitemid 34717695)
2. J. Arnt, and J. Hyttel Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI Eur. J. Pharmacol. 161 1989 45 51 (Pubitemid 19058846)
3. M.A. Benneyworth, Z. Xiang, R.L. Smith, E.E. Garcia, P.J. Conn, and E. Sanders-Bush A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis Mol. Pharmacol. 72 2007 477 484 (Pubitemid 47124127)
4. M.R. Braden, J.C. Parrish, J.C. Naylor, and D.E. Nichols Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists Mol. Pharmacol. 70 2006 1956 1964 (Pubitemid 44771911)
5. C.E. Canal, and D. Morgan Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model Drug Test. Anal. 4 2012 556 576
6. A. Dekeyne, S. Girardon, and M.J. Millan Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysis Neuropharmacology 38 1999 415 423 (Pubitemid 29097724)
7. 2A receptor antagonist, MDL100,907, elicits a specific interoceptive cue in rats Neuropsychopharmacology 26 2002 552 556 (Pubitemid 34261005)
8. N. Egashira, A. Shirakawa, R. Okuno, K. Mishima, K. Iwasaki, R. Oishi, and M. Fujiwara Role of endocannabinoid and glutamatergic systems in DOI-induced head-twitch response in mice Pharmacol. Biochem. Behav. 99 2011 52 58
9. Erowid 25I-NBOMe (2C-I-NBOMe) Dose 2013 http://www.erowid.org/chemicals/ 2ci-nbome/2ci-nbome-dose.shtml (Retrieved March 30, 2013)
10. A. Ettrup, M. Hansen, M.A. Santini, J. Paine, N. Gillings, M. Palner, S. Lehel, M.M. Herth, J. Madsen, J. Kristensen, M. Begtrup, and G.M. Knudsen Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers Eur. J. Nucl. Med. Mol. Imaging 38 2011 681 693
11. 11C]Cimbi-36 Mol. Imaging Biol. 15 2013 376 383
12. A. Ettrup, M. Palner, N. Gillings, M.A. Santini, M. Hansen, B.R. Kornum, L.K. Rasmussen, K. Någren, J. Madsen, M. Begtrup, and G.M. Knudsen Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET J. Nucl. Med. 51 2010 1763 1770
13. W.E. Fantegrossi, A.W. Harrington, J.R. Eckler, S. Arshad, R.A. Rabin, J.C. Winter, A. Coop, K.C. Rice, and J.H. Woods Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats Psychopharmacology 181 2005 496 503 (Pubitemid 41480898)
14. M.A. Geyer, and F.X. Vollenweider Serotonin research: contributions to understanding psychoses Trends Pharmacol. Sci. 29 2008 445 453
15. 2B receptors Behav. Pharmacol. 12 2001 613 620 (Pubitemid 34017107)
16. 2A receptor-mediated signaling pathways to affect behavior Neuron 53 2007 439 452 (Pubitemid 46161267)
17. A.L. Halberstadt, and M.A. Geyer Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens Neuropharmacology 61 2011 364 381
18. A.L. Halberstadt, and M.A. Geyer Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement Psychopharmacology 227 2013 727 739
19. 2A- rezeptoragonisten mit N-2-methoxybenzyl-partialstruktur Entwicklung eines neuen struktur-wirkungskonzepts 2003 Freien Universität Berlin Berlin http://www.diss.fu-berlin.de/diss/receive/FUDISS-thesis-000000001221 (Retrieved April 14, 2013)
20. S.L. Hill, T. Doris, S. Gurung, S. Katebe, A. Lomas, M. Dunn, P. Blain, and S.H.L. Thomas Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: case series Clin. Toxicol. 51 6 2013 487 492
21. 2A antagonist with a favorable CNS safety profile J. Pharmacol. Exp. Ther. 277 1996 968 981
22. A. Kelly, B. Eisenga, B. Riley, and B. Judge Case series of 25I-NBOMe exposures with laboratory confirmation Clin. Toxicol. 50 2012 702
23. G.J. Marek Behavioral evidence for mu-opioid and 5-HT2A receptor interactions Eur. J. Pharmacol. 474 2003 77 83 (Pubitemid 37289148)
24. 1) receptors suppresses head shakes induced by a serotonergic hallucinogen in rats Neuropharmacology 56 2009 1082 1087
25. J.L. Moreno, C. Muguruza, A. Umali, S. Mortillo, T. Holloway, F. Pilar-Cuéllar, G. Mocci, J. Seto, L.F. Callado, R.L. Neve, G. Milligan, S.C. Sealfon, J.F. López-Giménez, J.J. Meana, D.L. Benson, and J. González-Maeso Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function J. Biol. Chem. 287 2012 44301 44319
26. P.R. Moya, K.A. Berg, M.A. Gutiérrez-Hernandez, P. Sáez-Briones, M. Reyes-Parada, B.K. Cassels, and W.P. Clarke Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors J. Pharmacol. Exp. Ther. 321 2007 1054 1061 (Pubitemid 46762692)
27. D.E. Nichols Hallucinogens Pharmacol. Ther. 101 2004 131 181 (Pubitemid 38167565)
28. D.E. Nichols, S.P. Frescas, B.R. Chemel, K.S. Rehder, D. Zhong, and A.H. Lewin High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy- 4-iodophenethylamine (INBMeO): a high-affinity 5-HT2A receptor-selective agonist radioligand Bioorg. Med. Chem. 16 2008 6116 6123 (Pubitemid 351758826)
29. 2A receptor agonists J. Neurochem. 95 2005 1575 1584 (Pubitemid 41804055)
30. 3H]prazocin Brain Res. Protoc. 8 2001 191 198 (Pubitemid 33152944)
31. S.R. Rose, K.L. Cumpston, P.E. Stromberg, and B.K. Wills Severe poisoning following self-reported use of 25-I, a novel substituted amphetamine Clin. Toxicol. 50 2012 707 708
32. S.R. Rose, J.L. Poklis, and A. Poklis A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug Clin. Toxicol. 51 2013 174 177
33. C.L. Schmid, and L.M. Bohn Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivo J. Neurosci. 30 2010 13513 13524
34. C.L. Schmid, K.M. Raehal, and L.M. Bohn Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo Proc. Natl. Acad. Sci. U. S. A. 105 2008 1079 1084 (Pubitemid 351282084)
35. R. Schreiber, M. Brocco, V. Audinot, A. Gobert, S. Veiga, and M.J. Millan (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists J. Pharmacol. Exp. Ther. 273 1995 101 112
36. A. Shulgin, and A. Shulgin PIHKAL: a Chemical Love Story 1991 Transform Press Berkeley, CA
37. M.T. Silva, and H.M. Calil Screening hallucinogenic drugs: systematic study of three behavioral tests Psychopharmacologia 42 1975 163 171
38. 2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies J. Pharmacol. Exp. Ther. 266 1993 684 691 (Pubitemid 23318678)
39. S.J. Stellpflug, S.E. Kealey, C.B. Hegarty, and G.C. Janis 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing J. Med. Toxicol. 2013 (in press) http://dx.doi.org/10.1007/s13181-013-0314-y
40. 2C receptor agonists Pharmacol. Biochem. Behav. 69 2001 643 652 (Pubitemid 32758752)
41. F.X. Vollenweider, M.F. Vollenweider-Scherpenhuyzen, A. Bäbler, H. Vogel, and D. Hell Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action Neuroreport 9 1998 3897 3902 (Pubitemid 29189323)
42. T. Yamamoto, and S. Ueki Behavioral effects of 2,5-dimethoxy-4- methylamphetamine (DOM) in rats and mice Eur. J. Pharmacol. 32 1975 156 162
43. H.L. Yarosh, E.B. Katz, A. Coop, and W.E. Fantegrossi MDMA-like behavioral effects of N-substituted piperazines in the mouse Pharmacol. Biochem. Behav. 88 2007 18 27 (Pubitemid 47381540)
44. D. Zuba, and K. Sekuła Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs Test. Anal 2013 634 645
45. D. Zuba, K. Sekuła, and A. Buczek 25C-NBOMe - new potent hallucinogenic substance identified on the drug market Forensic Sci. Int. 227 2013 7 14